from the editor
Last week the ASX Healthcare and Biotechnology gained 1.66% to close on Friday 4 April at 3055 points. On a rolling monthly basis the index increased 4.96%. (NASDAQ Biotech Index gained 1.5% over the week and increased 10.9% for the month).
The rises of the week over 15% were: Inovax 46.34% Genetic Technologies 25%, AVT Holdings 22.22%, Clover 17.74 and Psivida 15.62%.
The falls of the week over 15% were: Ambri 18.18% and NSL Health 16.67%.
Below please find a summary of last week's most important Australian biotech news.
Regards,
Dr. Bengt Norrman
Editor
Biomedoz P/L
corporatescreeners.com
SBP
solbec pharmaceuticals limited
biotechs sector on the move
Add to My Watchlist
What is My Watchlist?